Literature DB >> 26884965

Association of susceptibility to septic shock with platelet endothelial cell adhesion molecule-1 gene Leu125Val polymorphism and serum sPECAM-1 levels in sepsis patients.

Wei Sun1, Fang-Shun Li1, Yuan-Huai Zhang1, Xiao-Ping Wang1, Chao-Rong Wang1.   

Abstract

Sepsis is a systemic inflammatory response to infection and includes severe sepsis, septic shock and death. Platelet endothelial cell adhesion molecule-1 (PECAM-1) is one cell adhesion molecule expressed on platelets and leukocytes. It regulates platelet activation and mediates transendothelial migration of leukocytes, thus maintaining the integrity of the vasculature. There are some animal experiments associated with the protective role of PECAM-1 against septic shock. However few host genetic risk factors have been identified for sepsis severity and susceptibility to septic shock. A case-control study was conducted, which included 217 patients with sepsis and 90 control subjects recruited from our hospital. One single nucleotide polymorphisms (SNP) of PECAM-1 gene Leu125Val (C373G) was analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Serum soluble PECAM-1 (sPECAM-1) levels were determined by enzyme-linked immunosorbent assay (ELISA). Our results showed that the CG and GG genotypes of SNP in Leu125Val of PECAM-1 (rs668: C>G) was significantly associated with increased susceptibility to septic shock compared with CC genotype in sepsis patients (CG genotype, OR: 2.493, 95% CI: 1.175~5.287, P = 0.016; GG genotype: OR: 3.328, 95% CI: 1.445~7.666, P = 0.004). The serum levels of sPECAM-1 in the sepsis patients (47.1 ± 17.5 ng/ml) were significantly higher than those in the healthy controls (61.3 ± 20.9 ng/ml, P<0.01). Among sepsis patients, the serum levels of sPECAM-1 were significantly higher in CG and GG genotype than in CC genotype. In septic shock patients, nonsurvivors (83.7 ± 12.6 ng/ml, n = 69) had a significantly higher serum sPECAM-1 level than the survivors (76.9 ± 12.7 ng/ml, n = 53) (P<0.01). In conclusion, PECAM-1 Leu125Val polymorphism and its sPECAM-1 levels are associated with sepsis severity and susceptibility to septic shock.

Entities:  

Keywords:  Sepsis; platelet endothelial cell adhesion molecule-1 (PECAM-1); septic shock; single nucleotide polymorphisms (SNPs)

Year:  2015        PMID: 26884965      PMCID: PMC4723810     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  32 in total

Review 1.  Endothelial activation, dysfunction and permeability during severe infections.

Authors:  Warren L Lee; W Conrad Liles
Journal:  Curr Opin Hematol       Date:  2011-05       Impact factor: 3.284

2.  Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity.

Authors:  Jamie R Privratsky; Cathy M Paddock; Oliver Florey; Debra K Newman; William A Muller; Peter J Newman
Journal:  J Cell Sci       Date:  2011-04-12       Impact factor: 5.285

3.  Shedding of PECAM-1 during HIV infection: a potential role for soluble PECAM-1 in the pathogenesis of NeuroAIDS.

Authors:  E A Eugenin; R Gamss; C Buckner; D Buono; R S Klein; E E Schoenbaum; T M Calderon; J W Berman
Journal:  J Leukoc Biol       Date:  2006-01-13       Impact factor: 4.962

4.  Association between platelet endothelial cellular adhesion molecule-1 polymorphisms and atherosclerosis: results of a study on patients from northern Italy.

Authors:  Florinda Listì; Calogero Caruso; Daniele Di Carlo; Colomba Falcone; Chiara Boiocchi; Mariaclara Cuccia; Giuseppina Candore
Journal:  Rejuvenation Res       Date:  2010 Apr-Jun       Impact factor: 4.663

5.  Platelet-endothelial cell adhesion molecule-1 gene polymorphism and its soluble level are associated with severe coronary artery stenosis in Chinese Singaporean.

Authors:  Heming Wei; Lu Fang; Sanual H Chowdhury; Nanling Gong; Zhuowei Xiong; Jie Song; Koon Hou Mak; Saizhu Wu; Evelyn Koay; Sunil Sethi; Yean Leng Lim; Subroto Chatterjee
Journal:  Clin Biochem       Date:  2004-12       Impact factor: 3.281

6.  Association of Leu125Val polymorphism of platelet endothelial cell adhesion molecule-1 (PECAM-1) gene & soluble level of PECAM-1 with coronary artery disease in Asian Indians.

Authors:  Lu Fang; Heming Wei; Sanual H Chowdhury; Nanling Gong; Jie Song; Chew Kiat Heng; Sunil Sethi; Tian Hai Koh; Subroto Chatterjee
Journal:  Indian J Med Res       Date:  2005-02       Impact factor: 2.375

7.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher
Journal:  Crit Care Med       Date:  1998-11       Impact factor: 7.598

Review 8.  Quantitative analysis of the association between interleukin-10 1082A/G polymorphism and susceptibility to sepsis.

Authors:  Lin Ouyang; You-Di Lv; Can Hou; Guo-Bao Wu; Zhi-Hui He
Journal:  Mol Biol Rep       Date:  2013-05-29       Impact factor: 2.316

9.  Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo.

Authors:  F Liao; J Ali; T Greene; W A Muller
Journal:  J Exp Med       Date:  1997-04-07       Impact factor: 14.307

Review 10.  Extending international sepsis epidemiology: the impact of organ dysfunction.

Authors:  Annette M Esper; Greg S Martin
Journal:  Crit Care       Date:  2009-02-23       Impact factor: 9.097

View more
  7 in total

1.  Endothelial protein C receptor polymorphisms and risk of sepsis in a Chinese population.

Authors:  Yanbing Liang; Xia Huang; Yujie Jiang; Yueqiu Qin; Dingwei Peng; Yuqing Huang; Jin Li; Suren R Sooranna; Liao Pinhu
Journal:  J Int Med Res       Date:  2017-02-13       Impact factor: 1.671

2.  Sirtuin 2 Regulates Microvascular Inflammation during Sepsis.

Authors:  Nancy Buechler; Xianfeng Wang; Barbara K Yoza; Charles E McCall; Vidula Vachharajani
Journal:  J Immunol Res       Date:  2017-04-19       Impact factor: 4.818

3.  PECAM-1 Leu125Val (rs688) Polymorphism and Diabetic Nephropathy in Caucasians with Type 2 Diabetes Mellitus.

Authors:  Matej Završnik; Stojan Kariž; Jana Makuc; Maja Šeruga; Ines Cilenšek; Daniel Petrovič
Journal:  Anal Cell Pathol (Amst)       Date:  2016-12-28       Impact factor: 2.916

4.  Involvement of TIMP-1 in PECAM-1-mediated tumor dissemination.

Authors:  Valsamma Abraham; Gaoyuan Cao; Andrew Parambath; Fareedah Lawal; Chakkrapong Handumrongkul; Robert Debs; Horace M DeLisser
Journal:  Int J Oncol       Date:  2018-05-25       Impact factor: 5.650

5.  Preservation of microvascular barrier function requires CD31 receptor-induced metabolic reprogramming.

Authors:  Kenneth C P Cheung; Silvia Fanti; Egle Solito; Federica M Marelli-Berg; Claudio Mauro; Guosu Wang; Anitha S Nair; Hongmei Fu; Silvia Angeletti; Silvia Spoto; Marta Fogolari; Francesco Romano; Dunja Aksentijevic; Weiwei Liu; Baiying Li; Lixin Cheng; Liwen Jiang; Juho Vuononvirta; Thanushiyan R Poobalasingam; David M Smith; Massimo Ciccozzi
Journal:  Nat Commun       Date:  2020-07-17       Impact factor: 14.919

6.  Soluble Pecam-1 as a Biomarker in Periprosthetic Joint Infection.

Authors:  Michael Fuchs; Andrej Trampuz; Stephanie Kirschbaum; Tobias Winkler; F Andrea Sass
Journal:  J Clin Med       Date:  2021-02-05       Impact factor: 4.241

7.  Association of PECAM-1 Gene Polymorphisms with Kawasaki Disease in Chinese Children.

Authors:  Zhuoying Li; Dong Han; Jie Jiang; Jia Chen; Lang Tian; Zuocheng Yang
Journal:  Dis Markers       Date:  2017-04-23       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.